Commack, New York
Cancer clinical trials in Commack, NY
131 cancer studies are recruiting participants at sites in Commack as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Commack at a glance
- 131 studies are recruiting at a site in Commack.
- By phase: Phase 1 (16), Phase 1/2 (8), Phase 2 (55), Phase 2/3 (1), Phase 3 (16), Phase 4 (3), No phase (13), Observational (19). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (114), industry (9), government (8).
- By research area: Breast Cancer (46), Lung Cancer (34), Lymphoma (24), Prostate Cancer (14), Pancreatic Cancer (10), Melanoma (3).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Commack
Basic details from each study's public record (the 30 most recently updated of 131). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT07488676 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT05564377 · updated
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Phase 3
- Ages 18 to 75
- Female participants
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Commack (Limited Protocol Activities)
- Registry record
- NCT06144164 · updated
A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After Mastectomy
- Phase 2
- Ages 18 and older
- Female participants
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities )
- Registry record
- NCT07918989 · updated
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Observational
- Ages 18 and older
- Female participants
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)
- Registry record
- NCT05590949 · updated
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk- Commack (Consent Only)
- Registry record
- NCT07218250 · updated
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
- Registry record
- NCT06954337 · updated
A Study of Skipping Radiation Therapy in People With Breast Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities )
- Registry record
- NCT07895511 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Commack, NY on ClinicalTrials.gov.
Lung cancer studies recruiting in Commack
A Study of Armored CAR T Cells in People With Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities)
- Registry record
- NCT07783477 · updated
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04181060 · updated
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT07293247 · updated
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)
- Registry record
- NCT06807632 · updated
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT01639508 · updated
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
- Registry record
- NCT06741085 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Commack, NY on ClinicalTrials.gov.
Prostate cancer studies recruiting in Commack
Radiation Therapy Approaches for People With Prostate Cancer
- Phase 2
- All ages
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)
- Registry record
- NCT07751159 · updated
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT03866382 · updated
A Study of Changes to Prostate Procedures
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk-Commack (Consent only)
- Registry record
- NCT06986083 · updated
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT06931340 · updated
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT07200830 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Commack, NY on ClinicalTrials.gov.
Lymphoma studies recruiting in Commack
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT02974647 · updated
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04269902 · updated
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04301076 · updated
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04840602 · updated
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Cancer Center @ Commack
- Registry record
- NCT03618550 · updated
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Suffolk - Commack
- Registry record
- NCT07231952 · updated
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04803201 · updated
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT07215910 · updated
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
- Phase 2
- Ages 65 to 80
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (Limited Protocol Activities)
- Registry record
- NCT06765317 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Commack, NY on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Commack
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT04858334 · updated
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Memorial Sloan Kettering Commack
- Registry record
- NCT07409272 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Commack, NY on ClinicalTrials.gov.
Ask about studies near Commack
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in New York
All New York locations
861 studies recruiting across 83 cities.
New York
649 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections